Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11520 posts found.

Avastin partners boosted by lung cancer data

March 17, 2005 Sales and Marketing

The share prices of Roche and Genentech have risen sharply on the back of news that Avastin extends the life …
News

BMS hepatitis drug set for approval

March 17, 2005 Sales and Marketing

Bristol-Myers Squibb's Baraclude (entecavir) has been recommended for first-line treatment of chronic hepatitis B despite potential cancer risks.The US Food …
News

US doctors oppose black box warning for eczema drugs

March 17, 2005 Sales and Marketing

US dermatologists have voiced their disapproval of new FDA restrictions on two eczema drugs because of potential cancer risks.The US …
News

MRC collaborates with Pfizer on enigmatic drug targets

March 16, 2005 Sales and Marketing

Pfizer has entered into a collaboration with the UK's Medical Research Council commercial arm to develop new drug discovery techniques.Medical …
News

Telemedicine ‘disappearing from the NHS’

March 16, 2005 Sales and Marketing

The hi-tech vision of doctors communicating with their patients via video, digital imaging and electronic data transmission is as far …
News

Biotech blockbusters push industry sales over $500 billion

March 14, 2005 Sales and Marketing

The global pharmaceutical industry achieved annual sales of over $500 billion for the first time ever in 2004, up 7% …
News

Pharma’s verdict on e-marketing

March 10, 2005 Sales and Marketing

Feature

Seroquel shows promise in Alzheimer’s

March 9, 2005 Sales and Marketing

New data shows AstraZeneca's blockbuster drug Seroquel to be effective in reducing agitation in elderly patients with Alzheimer's disease (AD).Seroquel …
News

SSRI guidance unchanged, says MHRA

March 9, 2005 Sales and Marketing

UK regulator the MHRA has reiterated its guidance on SSRI antidepressants and stressed their safety after a new article linked …
News

Potential blockbuster Tysabri pulled after patient death

March 9, 2005 Sales and Marketing

Elan and Biogen Idec have stopped marketing Tysabri (natalizumab), their new multiple sclerosis treatment, and asked doctors not to prescribe …
News

ABPI to oppose strictest measures in pan-European code of practice

March 3, 2005 Sales and Marketing

A pan-European code of practice is being drawn up by the pharmaceutical industry organisation EFPIA in response to continuing criticism …
News

GSK rebrands AIDS drugs to foil illegal imports

March 2, 2005 Sales and Marketing

GlaxoSmithKline has rebranded its Aids drugs supplied to sub-Saharan Africa to stop illegal re-importation to Europe.The company said parallel importers …
News

Singulair gains dual asthma-hayfever indication

March 2, 2005 Sales and Marketing

Merck Sharpe & Dohme's blockbuster oral asthma treatment Singulair has received an expanded UK licence for the treatment of adult …
News

NHS is behind us, says rep-free Takeda

March 1, 2005 Sales and Marketing Davis, Takeda, sales and marketing

Takeda UK says new market research shows healthcare professionals and NHS managers are in favour of its revolutionary move away …
News

Cymbalta approved for second indication

February 24, 2005 Sales and Marketing

Cymbalta has received European approval for diabetic peripheral neuropathic pain (DPNP) in adults, with its marketers keen to meet what …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025